KUSH PARMAR Insider Trading $AKUS Akouos, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KUSH PARMAR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KUSH PARMAR. KUSH PARMAR is Director in scPharmaceuticals Inc. ($SCPH) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in ARVINAS, INC. ($ARVN) and Director in Homology Medicines, Inc. ($FIXX) and Director in Akouos, Inc. ($AKUS) and Director in Vor Biopharma Inc. ($VOR) and Co-CEO in 5:01 Acquisition Corp. ($FVAM).
KUSH PARMAR in Akouos, Inc.
Trading Symbol: AKUSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KUSH PARMAR: Director
Holdings: 3,153,331 shares
Latest Transaction: Dec 31 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KUSH PARMAR in Akouos, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FVAM, AKUS, ARVN, BOLD, FIXX, SCPH, VOR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 111,648 | 2,009,664 | 982,453 | 1.1 M to 982.5 K (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 111,648 | 2,009,664 | 982,453 | 1.1 M to 982.5 K (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 358,352 | 6,450,336 | 3,153,331 | 3.5 M to 3.2 M (-10.20 %) |
Dec 31 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Sell | S | 18.00 | 358,352 | 6,450,336 | 3,153,331 | 3.5 M to 3.2 M (-10.20 %) |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 16,858,076 | 0 | 0 | |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 21,072,595 | 0 | 0 | |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 42,102,730 | 0 | 0 | |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Option Exercise | C | 0.00 | 10,826,417 | 0 | 0 | |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Buy | P | 17.00 | 294,117 | 4,999,989 | 1,094,101 | 800 K to 1.1 M (+36.77 %) |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 799,984 | 0 | 799,984 | 0 to 800 K |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 999,980 | 0 | 3,511,683 | 2.5 M to 3.5 M (+39.81 %) |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 1,997,946 | 0 | 2,511,703 | 513.8 K to 2.5 M (+388.89 %) |
Jul 02 2020 | AKUS | Akouos, Inc. | PARMAR KUSH | Director | Buy | C | 0.00 | 513,757 | 0 | 513,757 | 0 to 513.8 K |
Page: 1